Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Paired box protein Pax-6 (PAX6) is a highly conserved transcription factor characterized by a paired box DNA-binding domain and a homeobox domain, playing a central role in the development of the eye, central nervous system, nose, and pancreas. PAX6 regulates gene expression required for organogenesis and tissue patterning by directly activating or repressing genes involved in cell differentiation and proliferation. Mutations in PAX6 cause a range of ocular and neurodevelopmental disorders, most notably aniridia. Multiple isoforms with differing DNA-binding specificity result from alternative splicing and promoter usage. PAX6 interacts structurally with DNA through its paired domain and homeodomain, orchestrating complex regulatory networks crucial to embryonic and adult tissue formation.
For experimental modulation, mechanisms include upregulation or downregulation of gene expression via transcription factor binding to target gene promoters/enhancers; effects are mediated by altering transcriptional activation and repression through interaction with chromatin remodeling factors (e.g., SWI/SNF complex, histone acetyltransferase p300).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Paired box protein Pax-6 (PAX6).